Dr. Andrew Zelenetz of Memorial Sloan Kettering Cancer Center describes the expanding CLL and lymphoma armamentarium on location at the 2015 American Society of Hematology (ASH). Dr. Zelenetz and Carol Preston discuss the results of an international studydesigned to improve the current standard of carethat is now leading to a wealth of treatment choices. Says Dr. Zelenetz, We have the tools now to treat CLL in such a way that we can get deep remissions.
Sponsored by the Patient Empowerment Network through educational grants from Teva and Pharmacyclics.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo